← Latest papers
📄 medicine

Surgical Margins and the Risk of Local-Regional Recurrence Following Mastectomy

This study of mastectomy patients who did not receive radiation found that positive surgical margins significantly increase the risk of local-regional recurrence, suggesting margin status should be considered when deciding on adjuvant radiation therapy.

Original authors: Jordan Tralins, Yu-Hui Chen, Stuart Schnitt, Jennifer Bellon, Faina Nakhlis, Emma Mayette, Summer Westover, Laura Warren

Published 2026-10-22
📖 4 min read☕ Coffee break read

Original authors: Jordan Tralins, Yu-Hui Chen, Stuart Schnitt, Jennifer Bellon, Faina Nakhlis, Emma Mayette, Summer Westover, Laura Warren

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

When a surgeon removes a breast to treat cancer, the goal is to take out every trace of the disease. The tissue is examined under a microscope to see if the cut edges, known as margins, are clean. If cancer cells are found right at the edge of the removed tissue, or very close to it, doctors worry that some cancer might have been left behind in the body. This leftover tissue could potentially grow back in the chest wall or nearby lymph nodes, a problem called local-regional recurrence. For decades, the standard response to finding these close or positive edges has been to give patients radiation therapy after surgery to kill any remaining cells. However, modern treatments with chemotherapy and hormone therapy have become so effective that the overall risk of cancer returning has dropped significantly. This progress has led to a quiet but important question in the medical community: in an era where drugs are doing so much heavy lifting, is radiation still necessary for everyone with less-than-perfect surgical edges, or can we be more selective?

A team of researchers at Harvard Medical School and Dana-Farber Cancer Institute set out to answer this by looking closely at a specific group of patients. They studied records from 236 women who had a mastectomy between 2013 and 2015 and, crucially, did not receive radiation therapy afterward. By focusing on those who did not have the extra treatment, the researchers could see the natural risk of the cancer coming back based solely on the surgery and the drugs the patients received. They tracked these women for an average of nearly nine years, watching to see if the cancer returned to the chest wall or nearby lymph nodes. The researchers paid special attention to the condition of the surgical margins, categorizing them as negative (clean, with more than two millimeters of healthy tissue), close (cancer within two millimeters of the edge), or positive (cancer touching the edge).

The study revealed that the risk of recurrence was not the same for everyone. Among the women whose surgery left a positive margin, the chance of the cancer returning within eight years was twenty percent. For those with a close margin, the risk was lower, at seven and a half percent. In contrast, women with clean, negative margins had a very low risk of recurrence, at just under two percent. While the overall number of recurrences was small because modern drug therapies are so good at preventing them, the pattern was clear. The data showed that having cancer cells right at the edge of the surgery was strongly linked to a higher chance of the disease coming back. Specifically, women with positive margins faced a risk of recurrence that was nearly ten times higher than those with clean margins. Those with close margins also saw a higher risk, though the numbers were not large enough to be statistically certain in this specific group.

The researchers noted that their study had limits, primarily because the number of women who experienced a recurrence was small, which makes it difficult to draw broad conclusions for every type of patient. They also acknowledged that the doctors who treated these women might have chosen not to give radiation only to those they thought were at the lowest risk, which could skew the results. Despite these constraints, the findings add to a growing body of evidence suggesting that the status of the surgical margin matters. The study does not prove that radiation will definitely help everyone with a positive margin, nor does it say that radiation should be avoided. Instead, it suggests that the condition of the surgical edge is a significant factor that doctors should weigh when deciding whether to recommend radiation therapy. In a world where treatment options are increasingly personalized, knowing that a positive edge carries a distinct risk helps guide the difficult choices between additional treatment and the side effects it might bring.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →